YD Bio Limited YDES

Updated: 8 Aug 2026

NASDAQ | Biotech | Biotechnology and cancer diagnostics

No signal published yet

We already track YD Bio and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow YD Bio free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Biotechnology and cancer diagnostics
We're already tracking YD Bio Limited — here are the latest events we've registered

Recent News

  • In August 2026, YD Bio highlighted a peer-reviewed publication on a new computational framework for keratoconus research. In July 2026, the company launched a cross-border cancer testing pilot in Canada in partnership with Numia Health.

What Firelda Watch includes for YD Bio Limited

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of YD Bio Limited will be delivered in the same format.

Want to follow YD Bio Limited? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow YD Bio free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

YD Bio Limited YDES
YD Bio — follow and we'll monitor it
Follow YD Bio free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.